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Background: In a screening study for silent atrial fibrillation (AF), which is a frequent source of cardiac emboli with
ischemic stroke, the proportion of non-participants was considerable and their clinical profile differed from the
participants’ profile. We intended to geo-map the target population and non-participation in an attempt to
understand factors related to screening uptake and, thereby, obtain useful information needed to intervene for
improved uptake.
Method: In the municipality of Halmstad, Sweden, all residents born in 1934–1935 were invited to the screening
study during April 2010 to February 2012. The total study group included 848 participants and 367 non-participants
from 12 parishes. Geo-maps displaying participation, along with target-population-based geo-maps displaying
proportion of immigrants and ischemic stroke incidence, were used.
Results: Smoothed non-participation ratios (SmNPR) varied from 0.81 to 1.24 across different parishes
(SmNRP = 1 corresponds to the expected participation based on the total study group). Among high risk
individuals, the geographical variation was more pronounced (SmNPR range 0.75–1.51). Two parishes with
higher share of immigrants and elevated population-based ischemic stroke incidence showed markedly lower
participation, particularly among high-risk individuals.
Conclusion: AF screening uptake varied evidently between parishes, particularly among high-risk individuals.
Geo-mapping of target population and non-participation yielded useful information needed to intervene for
improved screening uptake.
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Atrial fibrillation (AF) is the most frequently encountered
clinical arrhythmia. Outcome is affected among patients
with AF with a higher mortality, higher risk of stroke, and
higher risk for hospitalizations [1-3]. At least one fourth
of stroke cases are associated with AF [4,5]. The true share
of patients with stroke associated with AF is not yet
known since the detection rate of AF is depending on the
duration and mode of ECG monitoring [6-8]. AF is a
major contributor to healthcare expenditure, particularly
because of the costs for stroke care [9]. Stroke associated* Correspondence: johan.engdahl@regionhalland.se
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reproduction in any medium, provided the orwith AF also inflict a larger neurologic deficit and have a
higher mortality [10,11].
AF can sometimes be present without symptoms, often
referred to as silent AF. When silent AF is paroxysmal,
diagnosis might be difficult. The actual frequency of silent
AF in the population is not yet known. Silent AF is
connected to an increased risk of stroke [12]. Furthermore,
patients with symptomatic paroxysmal AF often have AF
episodes without symptoms, making symptoms unreliable
for the estimation of AF burden [13].
Oral anticoagulation (OAC) therapy is the recommended
treatment for stroke prophylaxis in patients with AF and
thromboembolic risk factors.
Hence, screening for silent AF seems suitable in risk pop-
ulations. We (JE and MR) have initiated such a screeningl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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initial screening study have been reported elsewhere
[14]. In our initial screening study, the proportion of
non-participants, including those who did not respond to
the screening invitation and those who actively denied
participation, was considerable and their clinical profile
related to stroke risk differed from the participants’ profile
[14]. This called for a thorough analysis of screening
uptake.
A few determinants of non-participation have reported
from a two other AF screening studies. In a study in the
UK including individuals over 65 years of age, problem
getting to the clinic was the most frequent stated reason for
not attending [15]. Clearly, there might have been various
underlying factors related to this reason. Elderly persons
(>75 years) were less likely to participate. We speculate that
residence area played a role. In an AF screening study
among 75-year old inhabitants in a Norwegian community,
socioeconomic determinants of participation, such as higher
income and educational level, were reported and participa-
tion was 82% [16]. Clinical profile (related to stroke risk),
spatial and socioeconomic factors provide a framework of
covariates to consider with respect to AF screening
program participation.
Our objective was to geo-map the target population
and non-participation in an attempt to understand factors
related to screening uptake and, thereby, obtain useful
information needed to intervene for improved uptake. In
the present report we apply a novel approach, using
geo-maps, to analyze participation in a community-
wide screening program for AF and its geographical
(neighborhood area) relation to cardiovascular risk and
immigrant group status.
Methods
Study area and data based on target population
The municipality of Halmstad is located in the southwest
of Sweden and consists of 12 parishes. The total population
was 91,800 inhabitants by January 1st 2010. Figure 1 shows
the parish-level population size for the inhabitants aged
75–79 years. On December 31st 2012, the municipality had
14.6% immigrants and the five largest immigrant groups
were from former Yugoslavia, Bosnia & Hercegovina, Iraq,
Poland and Finland.
Statistics Sweden provided parish-level data on the
proportion of immigrants among all residents aged
75–79 years. The Swedish population registry contains
information on birth country, as well as residence
area in Sweden, for each citizen.
Population-based data on ischemic stroke incidence
were obtained for the residents aged 70+ years in the
calendar period 2006–2010. For each calendar year, we
stratified the population by sex and age group (70–74,
75–79, 80–84 and 85+). The ischemic stroke cases in eachstratum were obtained from the regional in-patient
registry (in total, n = 959). The resulting parish-specific
standardized incidence ratios (SIRs) (see Statistical methods)
reasonably reflect the predicted SIRs for the target
population, provided unchanged impact of underlying
risk factors. In other words, assuming that the target
population will be followed prospectively, the SIRs
provide reasonable information regarding the expected
ischemic stroke risk variation in the study area. Data
on stroke incidence derive from Swedish inpatient
statistics, provided by The National Board of Health
and Welfare. Stroke diagnosis is derived from discharge
reports without conditions regarding level of care or
investigations undertaken.
Study group and individual stroke risk factors
The screening study was approved by the regional
health research ethics board at Lund University,
Sweden, and conducted according to the declaration
of Helsinki.
All residents in Halmstad municipality born in 1934
and 1935 were invited to the AF screening program,
which was performed during April 2010 to February
2012. The study invitation was sent by mail; if there was
no response within 4–6 weeks, a reminder was sent.
Screening visits were undertaken at a single centre at the
hospital. The total study group included 848 participants
(484 women) and 367 non-participants (213 women) from
the 12 parishes (overall participation = 70%). We had to
disregard 75 persons who actively declined study inclusion
since we could not geo-code those persons, nor collect
clinical data on ethical grounds. Hence, the present
definition of “non-participation” refers to those who
did not respond to the invitation. The absolute overall
non-participation reported elsewhere [14] was therefore
somewhat higher than the non-participation rates
(percentages) reported in the present study.
At the index visit, all participants were asked to re-
port their medical history including presence of AF,
antithrombotic treatment and thromboembolic risk
factors according to the CHADS2 (Congestive heart failure,
Hypertension, Age > 75, Diabetes Mellitus, previous Stroke)
risk classification [17]. If a patient reported a previously
known diagnosis of AF, this had to be confirmed by ECG
recordings in the medical records. Medical records search
was made only among those participants who stated that
they had an AF diagnosis and among participants with AF
on ECG recordings obtained in the screening process. The
accuracy of the self-reported medical history was confirmed
by medical records in patients with AF. However, a random
subset of 80 out of 727 patients with the questionnaire as
the sole source of medical history was cross-checked
against medical records in hospital and primary care, and
against prescriptions. One of the 80 patients had
Figure 1 Geo-map on population size in the age stratum 75–79 years, calendar year 2010, divided with respect to 12 parishes in the
municipality of Halmstad, Sweden. Pie size is proportional to population size.
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in the remaining 79 cases, medical history was reported
correctly.
A 12-lead ECG was recorded at index visit. We
hypothesized that the diagnostic yield would be
higher among patients with at least one of these risk
factors, hence participants with a CHADS2-score of
at least 2 and with no known AF after index visit
were offered extended ECG recording with a hand-held
event recorder (Zenicor Medical Systems, Sweden) and
instructed to record 20 or 30 seconds of ECG twice daily
for two weeks. Further details on the screening study
are reported elsewhere [14]. Medical records from
inhabitants who did not participate in the screening
program were manually analysed with respect to AF
diagnosis, presence of anticoagulation treatment and
risk factors according to CHADS2. Both hospital and
primary care records and prescriptions were studied.
Non-participants were informed via letter and adver-
tisement about this data collection and were thereby
offered the possibility to withdraw their participation
in this part of the study.
Individual data on stroke risk factor scores (CHADS2)
were available for the 848 participants and 354 non-
participants. We also analyzed data restricted to high risk
individuals, defined as having CHADS2 ≥ 2.Statistical methods
Population-based data: ischemic stroke incidence
Each inhabitant was geo-coded with respect to his/her
neighborhood area (parish). Geo-maps of were produced
by using ESRI® ArcGIS system (Environmental Systems
Research Institute, Inc., USA). The geo-map on ischemic
stroke incidence was produced by computing the
smoothed standardized incidence ratios (SIRs) for each
parish, using the free software Rapid Inquiry Facility,
which provides an extension to ESRI® ArcGIS functions
[18,19]. The expected numbers of ischemic stroke epi-
sodes were obtained from the sex-, age- and calendar
year-specific rates for the municipality of Halmstad
(the following age groups were used: 70–74, 75–79,
80–84 and 85+). We applied the same smoothing
procedure as for the participation geo-maps (see below).
Data from the screening study: non-participation
A parish-level non-participation ratio (NPR) was calculated
as the observed-to-expected ratio, where the expected
number of non-participants was obtained from the sex-
specific non-participation rates for the total study group.
Hence, NPR > 1 indicates lower participation than expected
based on the data from total study group. Moreover, for
each parish, a smoothed NPR (SmNPR) were obtained by
running the empirical Bayesian mapping model, using a
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rate ratios [18,20]. More specifically, we first calculated
observed-to-expected ratios (Oi/Ei) to estimate the parish-
specific non-participation ratios (NPRi for parish i). We
applied the conventional statistical Poissonmodel for the
observed numbers: Oi ~ Poisson(NPRi×Ei). The empirical
Bayes smoothing of the NPRi:s across the parishes
was performed using a prior Gamma-model: NPRi ~
Gamma(α, β). Such Bayesian smoothing yielded “shrinkage”
of the conventional observed-to-expected ratios (NPRs)
towards the expected average NPR = 1. We underline that,
for a parish with few study persons, more pronounced
shrinkage of an elevated/lowered NPR was obtained, as
compared with a parish with a large number of study
persons. Hence, by presenting smoothed geo-maps of
participation, rational adjustments of the parish-specific
NPRs are taken into account [19-21]: the results have
higher specificity, at the price of somewhat lower sensiti-
vity, when inferring to repeated studies. Along with a
smoothed geo-map of participation, we present a statis-
tical certainty geo-map based on the posterior prob-
abilities of a parish-specific NPR above 1 given the
data, denoted Pr(NPR>1|data).
The proportions of high risk individuals and stroke
risk factors among the participants and non-participants,Figure 2 Geo-map on proportion of immigrants based on the popula
Halmstad, Sweden; divided into 12 parishes (range: 2-22%).respectively, were compared by Fisher’s exact test. More-
over, for the high risk individuals, the CHADS2 scores
between the participants and non-participants were
compared by the Mann–Whitney test.
Results
Data based on target population: proportion of
immigrants and ischemic stroke incidence
The proportion of immigrants among the residents
aged 75–79 years varied notably across the parishes
(range 2-22%; Figure 2). Also, ischemic stroke incidence in
the elderly population (70+ years) varied across the
parishes (smoothed SIR range: 0.80–1.13; Figure 3).
Data from the screening study: prevalence of AF and
stroke risk factors
Data on stroke risk factors was available from 352 of 367
non-participants. Non-participants more frequently had a
history of heart failure, diabetes mellitus and stroke/TIA.
As a consequence, their mean CHADS-score was signifi-
cantly higher in comparison to participants (Table 1).
Data from the screening study: non-participation
There was no difference in participation between men
and women. The proportion of high risk individuals wastion aged 75–79, calendar year 2010, in the municipality of
Figure 3 Geo-map on ischemic stroke incidence in the population aged 70+ years, calendar period 2006–2010, in the municipality of
Halmstad, Sweden; divided into 12 parishes. The ischemic stroke cases were obtained from the regional in-patient registry (in total, n = 959).
The smoothed standardized incidence ratios (SIRs) for each parish are shown (range: 0.80-1.13), which reasonably reflect the predicted SIRs for the
target population, provided unchanged impact of underlying risk factors.
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non-participants (491/848 = 58% vs. 217/354 = 61%,
p = 0.30; Figure 4). Considering the high risk individuals,
the participants had significantly lower CHADS2 -scores
than the non-participants (mean CHADS2 –score 2.48 vs.
2.74, p < 0.001; Figure 4).Table 1 Baseline characteristics including stroke risk
factors among individuals attending and not attending
the screening programme
Clinical characteristics n, (%)
Participating Non-participating
n=848 n=352 p
Male gender 364 (43%) 149 (42%)
Previously diagnosed AF 81 (9%) 39 (11%)
Heart failure 30 (4%) 34 (10%) <0.001
Hypertension 446 (53%) 185 (53%)
Diabetes mellitus 91 (11%) 60 (17%) 0.004
Previous stroke/TIA 80 (9%) 49 (14%) 0.02
CHADS2 –score (mean)* 1.85 2.08 0.05
* CHADS2 –score was calculated regardless of diagnosis of AF.The parish-specific non-participation rates ranged
between 18% and 48%. The smoothed geo-map based on
the total study group displayed geographical variation
in participation; SmNPR varied from 0.81 to 1.24 in
different parishes (Figure 5).
Among the high risk individuals the geographical
variation in participation was more pronounced. The
non-respondent rates ranged between 17% and 59%
and the SmNPR between 0.75 – 1.51 (Figure 6). We
underline that the participation among the high risk
individuals varied across the parishes. Two parishes
with a relatively dense elderly population (parishes E
and J in Figure 1), high proportion of immigrants
(Figure 2), and elevated population-based ischemic
stroke incidence (Figure 3), showed statistically evidently
lower participation (Figures 5 and 6). In those two
parishes, the proportions of high risk individuals were
notably higher among the non-participants than among
the participants (parish E: 16/22 = 73% vs. 11/24 = 46%;
parish J: 75/110 = 68% vs. 119/203 = 59%). Consequently,
the corresponding SmNPRs became more pronounced
when considering participation among the high risk
individuals (Figures 5 and 6).
Figure 4 The distribution of the individuals of the atrial fibrillation screening study according to their CHADS2 scores, among the
participants and non-participants, respectively.
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Participation in this AF screening program varied
evidently between parishes, in particular among high
risk individuals, i.e. individuals that would benefit the most
from anticoagulation treatment in case of an AF diagnosis.
In addition, low participation was linked to higher stroke
incidence and higher proportion of immigrants in the
target population.
The reasons for this geographical variation could be
manifold. High risk individuals might have had disabilities
which affected their participation. Individuals with dementia
and individuals staying at nursing homes were most
probably non-responders to the screening invitation,
but also in most cases not eligible to OAC treatment in
case of a new AF diagnosis. A more thorough examination
or interview of non-responders could have identified
patients with different disabilities making participation in
the screening program difficult. These data was not always
available in the medical records. However, the prevalence
of a previous stroke, heart failure and diabetes mellitus
was significantly higher among non-respondents which
would imply higher risk of disability, but data on the
level of disability after stroke was not part of our data
collection.
The two parishes with the lowest participation in the
screening program had the highest levels of elderly
immigrants among the population. Decreased ability tounderstand the written invitation might have impaired
participation. The invitation was written in Swedish
and had no condensed information or links in other
languages. The participants had to schedule their index
visit via a telephone call to the study center. One might
speculate that this procedure affected participation and
that providing the participants with a pre-scheduled
appointment could increase the response rate.
In our screening study, all examinations were performed
at one hospital clinic (located in parish K, see Figure 1). We
speculate that problem with getting to the clinic may have
affected participation in our study. In a multi-practice,
cluster randomized AF screening study in the UK
comparing systematic screening with opportunistic
screening and no screening in routine care among individ-
uals with age > 65 years, participation in systematic screen-
ing was 53% but varied between 22 and 68% at practice
level [15]. Participation was higher among invited individ-
uals < 75 years of age, but the yield of newly diagnosed AF
was higher among those > 75 years of age. Among non-
participants who stated their reason for not attending,
problem with getting to the clinic was the most frequently
stated reason [15]. In an AF screening study among 75-year
old inhabitants in a Norwegian community reported by
Tveit and coworkers, participation was 82% [16]. This study
offered home visits to disabled inhabitants. It was reported
that the study population had higher average income and
Figure 5 Geo-map on participation in pilot screening study for AF, conducted in the municipality of Halmstad, Sweden; divided into
12 parishes (total study group, 848 participants and 367 non-participants). For each parish, a smoothed non-participation ratio (SmNPR)
was calculated (range: 0.81 – 1.24; SmNRP = 1 corresponds to the expected participation based on the total study group). A corresponding
statistical certainty map based on the calculated posterior probabilities of a parish-specific NPR above 1 given the data [Pr(NPR>1|data)] is also
shown [light red color, Pr(NPR>1|data) > 0.90, i.e. a parish with data yielding moderate statistical evidence of lower participation].
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visits and socioeconomic status might have influenced
participation in this study [16].
Furthermore, our screening program was not accom-
panied by a media campaign.
In cancer screening settings, several factors that
may influence participation have been addressed; and
interventions as well as targeted actions for improving
participation have been proposed [22-24].
Our results yielded useful information needed to
intervene for improved screening uptake. The result
points towards specific neighborhood areas for possible
target actions. Yet, it might be feasible to use a modified
invitation procedure for the total study group. Nevertheless,
we anticipate that such an intervention will have greatest
potential effect in the parishes with relatively high share
of immigrants.Although the share of immigrants and the share of
non-participants not speaking Swedish fluently was
unknown to us, the screening uptake might be increased
by modifying the invitation letter, giving brief information
and links in several languages.
Previous studies on screening for AF among elderly
people have reported the significance of easy access
to the screening center [15]. Performing the ECG
screening closer to the participant, for instance in
collaboration with primary care might increase screening
uptake. As an extension of this modification, per-
forming ECG screening via home visit in selected
cases might increase screening uptake as well, although
selection of these cases might prove difficult. Screening
partly via home visits would also increase screening
costs and would perhaps negatively influence cost
effectiveness.
Figure 6 Geo-map on participation for the high risk individuals in pilot screening study for AF, conducted in the municipality of Halmstad,
Sweden; divided into 12 parishes (in total, 491 participants and 217 non-participants among the high risk indivduals). For each parish,
a smoothed non-participation ratio (SmNPR) was calculated (range: 0.75–1.51; SmNRP = 1 corresponds to the expected participation based on the total
study group). A corresponding statistical certainty map based on the calculated posterior probabilities of a parish-specific NPR above 1 given the data
[Pr(NPR>1|data)] is also shown [dark red color, Pr(NPR>1|data) > 0.95, i.e. a parish with data yielding strong statistical evidence of lower participation;
light red color, Pr(NPR>1|data) > 0.90, i.e. a parish with data yielding moderate statistical evidence of lower participation].
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Sweden is high. For instance, 83% of invited 65-year-old
men accepted to participate in aortic abdominal aneurysm
screening in the Uppland region in Sweden [25]. Since
our screening study was neither accompanied by a media
campaign nor being part of an established screening pro-
cedure, screening uptake in a future routinely performed
program might be higher than in this pilot study.
These measures will be subject to forthcoming studies.
Neighborhood areas with a high proportion of immigrants
among the elderly and elevated stroke incidence, which
enforce screening aiming at stroke prevention, are the
primary targets for action.
We have demonstrated that geo-maps on participation
in our initial screening program for silent AF, along
with target-population-based geo-maps on proportionof immigrants and ischemic stroke incidence, can provide
valuable information in order to tailor efforts to improve
participation in future screening programs.
Limitations
Clinical and geographical data were not available from
the 75 individuals who actively denied participation. If
these 75 individuals were unevenly distributed among the
12 parishes, this might have altered our results slightly.
We were able to geo-code the study population into
12 different parishes. The empirical Bayes model applied
means that we performed a “global” smoothing across
the 12 parishes. A fully Bayseian approach provides an
alternative option. By applying such an approach, a
“local” smoothing is added, i.e. allowing also for depend-
ency between rates in adjacent areas. A fully Bayesian
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the study population into several small areas. With the
12 different areas (parishes) considered, however, the
fully Bayesian approach in Rapid Inquiry Facility along
with free software for Bayesian data analysis, WinBugs
[26] yielded an overly marked smoothing: For the total
study group, those smoothed non-participation ratios
varied between 0.95-1.06 across the 12 parishes and, for
the high risk individuals, between 0.94-1.11.
Regarding individual-level data for the non-participants,
there was limited access to socio-demographic character-
istics due to ethical restrictions. In fact, the individuals of
the study population could only be stratified on
stroke risk factors (we used the CHADS2-score) and
sex, in order the perform Bayesian smoothing of non-
participation rates across the parishes. Provided richer
data, geographically-weighted regression offers an inter-
esting alternative method to identify spatial discrepancies
in observed-to-expected ratios [27].
Data on thromboembolic risk factors among non-
participants were collected from medical records which
has certain limitations.
Our data were too spare for analyzing participation
among high risk individuals defined by a more strict
definition than CHADS2 ≥ 2.
Conclusion
In conclusion, participation in an initial AF screening pro-
gram varied notably between parishes, in particular among
high risk individuals. Low participation was linked to higher
stroke incidence and higher proportion of immigrants in
the target population. Geo-maps on different aspects
of participation provided useful information needed to
intervene for improved screening uptake.
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